---
title: "Activation of EPHA2-ROBO1 heterodimer by SLIT2 attenuates non-canonical signaling and proliferation in squamous cell carcinomas"

# Publication name and optional abbreviated publication name.
publication: "*iScience*, *23*, 11. <a href='https://doi.org/10.1016/j.isci.2020.101692' target='_blank' rel='noopener noreferrer'>doi.org/10.1016/j.isci.2020.101692</a>"

#publication_short: 

authors:
- Saumya Srivastava
- Ka Ming Pang
- Mari Iida
- Michael S Nelson
- Jiayi Liu
- Arin Nam
- Jiale Wang
- Isa Mambetsariev
- Raju Pillai
- Atish Mohanty
- Nellie McDaniel
- Amita Behal
- Prakash Kulkarni
- Deric L Wheeler
- Ravi Salgia

publication_types:
- "2"

# Show publication and sharing statistics? (requires valid doi)
add_badge: true

featured: true

date: "2020-11-20T00:00:00-04:00"

doi: "https://doi.org/10.1016/j.isci.2020.101692"

external_link: 

links: 
 - name: PDF
   url: "https://www.cell.com/iscience/pdf/S2589-0042(20)30884-1.pdf"
# - name: Supplemental Material
#   url: "https://peerj.com/articles/7310/#supplemental-information"

abstract: "The tyrosine kinase receptor ephrin receptor A2 (EPHA2) is overexpressed in lung (LSCC) and head and neck (HNSCC) squamous cell carcinomas. Although EPHA2 can inhibit tumorigenesis in a ligand-dependent fashion via phosphorylation of Y588 and Y772, it can promote tumorigenesis in a ligand-independent manner via phosphorylation of S897. Here, we show that EPHA2 and Roundabout Guidance Receptor 1 (ROBO1) interact to form a functional heterodimer. Furthermore, we show that the ROBO1 ligand Slit Guidance Ligand 2 (SLIT2) and ensartinib, an inhibitor of EPHA2, can attenuate growth of HNSCC cells and act synergistically in LSCC cells. Our results suggest that patients with LSCC and HNSCC may be stratified and treated based on their EPHA2 and ROBO1 expression patterns. Although ~73% of patients with LSCC could benefit from SLIT2+ensartinib treatment, ~41% of patients with HNSCC could be treated with either SLIT2 or ensartinib. Thus, EPHA2 and ROBO1 represent potential LSCC and HNSCC theranostics."

# ####################################################################


# Featured image
# To use, add an image named `featured.jpg/png` to your page's folder. 
# image:
#  caption: 'Image credit: [**Unsplash**](https://unsplash.com/photos/s9CC2SKySJM)'
#  focal_point: ""
#  preview_only: false

# Associated Projects (optional).
#   Associate this publication with one or more of your projects.
#   Simply enter your project's folder or file name without extension.
#   E.g. `internal-project` references `content/project/internal-project/index.md`.
#   Otherwise, set `projects: []`.
# projects:
# - internal-project

# Slides (optional).
#   Associate this publication with Markdown slides.
#   Simply enter your slide deck's filename without extension.
#   E.g. `slides: "example"` references `content/slides/example/index.md`.
#   Otherwise, set `slides: ""`.
slides: example

math: true

# Summary. An optional shortened abstract.
# summary: Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.

tags: []

url_code: 'https://github.com/jiayiliujiayi/tcga_lusc-survival-kmplot'
#url_dataset: 'https://figshare.com/articles/dataset/Untitled_Item192_samples_for_publishing_Longitudinal_gut_microbiota_patterns_in_preterm_infants_with_necrotizing_enterocolitis_or_late-onset_sepsis_an_observational_prospective_study_/7205102/3'
url_pdf: 'https://www.cell.com/iscience/pdf/S2589-0042(20)30884-1.pdf'
#url_poster: '#'
#url_preprint: '#'
#url_project: '#'
#url_slides: '#'
#url_source: '#'
#url_video: 'https://vimeo.com/209325612'
---
